Regardless of the direction of P perfusion, the major compounds released from the liver were P, phenylgucuronide, phenylsulfate, hydroquinone (HQ), and HQ glucuronide. A comparison of the results of perfusing P in the orthograde versus the retrograde direction showed that more P was recovered unchanged and more HQ was formed during retrograde perfusion. The results suggest that enzymes involved in P hydroxylation are generally closer to the central vein than those involved in conjugation, and that during retrograde perfusion, P metabolism may be limited by the sub-optimal conditions of perfusion. Comparison of the orthograde perfusion studies of P and BZ revealed that a larger percentage of the radioactivity released from the liver was identified as unconjugated HQ after BZ perfusion than after P perfusion. In addition, the amount of radioactivity covalently bound to liver macromolecules was measured after each perfusion and determined to be proportional to the amount of HQ and HQG detected in the perfusate samples.
The hematotoxic effects of benzene (BZ) are thought to be caused by one or more of the metabolites of BZ (Andrews et al., 1977; Sammett et al., 1979) . Phenol (P) is the major metabolite produced during BZ metabolism in vivo (Parke and Williams, 1953) and in vitro (Gonasun, et al., 1973) . The administration of P to animals, however, results in neither BZ-induced hematotoxicity (Guy et al., 1990) nor BZ-induced carcinogenicity (Huff et al., 1989; National Cancer Institute, 1980) . However, hydroquinone (HQ), a metabolite of both BZ and P, is hematotoxic (Guy et al., 1990; Kalf et al., 1990) . For these reasons, the metabolism of both BZ and P have been studied using various in vivo and in vitro techniques Schlosser et al., 1993; Snyder et al., 1993) . Since the liver is the major site of BZ metabolism, and hepatic metabolism is a necessary precursor to its hematotoxicity (Sammett et al., 1979) , many of the in vitro studies have focused on the ability of hepatic enzymes to produce possible toxic intermediates, such as HQ, during incubation with either BZ or P (Schlosser et al., 1993; Snyder et al., 1993) . The in vivo studies have investigated which metabolites can be isolated from the urine, blood, and/or tissues of animals treated with BZ or P Sabourin et al., 1987 Sabourin et al., , 1989 . The results of studies investigating BZ and/or P metabolism have shown differing levels of hydroxylation depending on whether the experiments were done in vivo or in vitro. In vivo metabolism of BZ in the mouse leads to a greater percentage of the dose being converted to HQ than does the metabolism of an equal dose of P Sabourin et al., 1989) . This result, along with the hematotoxicity of HQ suggests that unconjugated HQ may leave the liver, travel to the bone marrow, and play a role in BZ-induced hematotoxicity. To the contrary, results from in vitro studies using mouse microsomes show that more HQ is formed after incubation of P than after incubation with BZ (Schlosser et al., 1993) . Schlosser et al. (1995) suggested the heterogeneous distribution of xenobiotic metabolizing enzymes within the liver acinus could explain both the differences seen during in vivo and in vitro metabolism of BZ and P, and possibly the lack of hematotoxicity seen after exposure to P. Additionally, Gilmour et al. (1986) , using rat liver microsomes, demonstrated that the incubation of [ 14 C]BZ together with increasing amounts of P did not result in a corresponding decrease in the amount of [ 14 C]HQ formed, suggesting that BZ may be a better substrate for the formation of HQ.
It has been shown that in the periportal region of the liver, activity of sulfotransferases is greater than in the pericentral region, while CYP 2E1, the major isozyme of cytochrome P450 involved in BZ and P hydroxylation (Koop et al., 1989) , activity is greater in the pericentral region (El Mouelhi and Kauffman, 1986; Gebhardt, 1992; Ingelman-Sundberg et al., 1988; Pang and Terrell, 1981; Tsutsumi et al., 1989) . Glucuronyl transferase activity is believed to be relatively equally distributed across the liver sinusoid (Gebhardt, 1992) . Thus, BZ could enter the liver acinus via the portal vein and, because it lacks an appropriate functional group, bypass conjugating enzymes and undergo hydroxylation in the pericentral region. Given a lower level of sulfate conjugation in the pericentral area, some unconjugated hydroxylated products such as P and HQ would leave the liver and enter the general circulation. By the same token, it would be suggested that P encounters conjugating enzymes immediately upon entering the periportal region, and little P would be available for further hydroxylation to HQ or other metabolites, in the pericentral region. The possible role of unconjugated P and HQ in BZ-induced hematotoxicity is supported by various studies where joint administration of P and HQ led to enhanced hematotoxicity, which had not occurred with either compound alone (Eastmond et al., 1987; Guy et al., 1990; Subrahmanyam, et al., 1990) .
To more accurately determine the metabolites of BZ emerging from the liver, Hedli et al. (1997) measured these metabolites released by the intact murine liver following perfusion of radiolabeled BZ in the orthograde direction after a single pass, or several passes, and after a single pass in the retrograde direction. The results suggested that more unconjugated BZ metabolites were released by the liver after single-pass orthograde perfusion than after any other treatment. The studies reported here were performed to determine whether single pass orthograde perfusion with P would result in greater recovery of conjugated P from the liver and less unconjugated P metabolites. In addition, retrograde P perfusion was investigated to further examine if the heterogeneous distribution of hepatic metabolizing enzymes is responsible for the differences in the metabolism, and possibly the hematotoxicity, of P and BZ. Animals. These studies were conducted under established federal regulations for the care and use of laboratory animals and were approved by the Rutgers University Institutional Animal Care and Use Committee. Male Swiss Webster albino mice, 6-weeks-of-age, were purchased from Taconic Farms, Germantown, PA. They were allowed to acclimatize in the animal facility for a minimum of 3 days and were used within 3 weeks of purchase. They received laboratory chow and water ad libitum and were kept on a 12 h-light/dark cycle. Animals received a single intraperitoneal (ip) injection of isopropyl alcohol (2 ml/kg) in saline, approximately 18 h prior to surgery. This was done to induce CYP 2E1, the principal isozyme of CYP involved in P hydroxylation. Animals were anesthetized with an ip injection of 50 mg/kg sodium pentobarbital 15 min prior to performing surgery to remove the liver.
MATERIALS AND METHODS

Chemicals
Surgical procedure, liver perfusion, and HPLC analysis. The protocols for these procedures can be found in Hedli, et al. (1997) and were followed exactly, with the following exceptions: perfusate samples were collected continuously in 6.7-ml vials containing 70 l of 1 M ascorbic acid, for the first 5 min, allowing 3 samples to be collected per min. From the 6th to the 15th min, 6.7-ml fractions were collected at the start of every min, so that only 1 sample was collected per min.. No recirculation of perfusate, using [
14 C]P as substrate, was performed.
Perfusion of radiolabeled phenol. [
14 C]P, specific activity 30 -110 mCi/ mmole, was dissolved in Krebs-Henseleit bicarbonate buffer prior to use, to give a concentration of 16.66 Ci/ml. Three ml of this solution was delivered at a rate of 1 ml/min to 37°C perfusate flowing at a rate of 20 ml/min into the liver. The concentration of P reaching the liver in all experiments was approximately 0.833 Ci/ml or 7.57-27.8 M.
Quantity of radioactivity in perfusate. Assuming no loss of P during dissolution and injection, the amount of infused radioactivity that could be accounted for in the collected perfusate was only between 24 -76%. HPLC analysis of the P solution done immediately before liver infusion showed greater than 95% purity; however, in some experiments as much as 60% of the expected radioactivity had been lost before infusion. The loss of this radioactivity may have occurred either prior to shipping or when the P was dissolved and transferred from its original vial. When these measurements are all considered, greater than 80% of the radioactivity can be accounted for in the perfusate in all experiments. A very small percentage of P may have been lost due to its volatility; in addition, approximately 5% was lost during infusion into the liver because of dead space in the syringe and tubing.
Quantification of covalently bound compounds. Liver samples weighing approximately 0.4 grams were homogenized in 5 ml of toluene. The homogenate was pelleted by centrifugation at 9000 ϫ g for 20 min. The supernatant was discarded and the pellet was resuspended in 5% trichloroacetic acid and centrifuged as above; this step was carried out twice. Resuspension and centrifugation of the pellet was repeated with methanol:ether (3:1) and 80% methanol until no radioactivity remained in the supernatant. The tissue was then dried, weighed, and burned to [ 14 C]CO 2 in a Packard, model 307 sample oxidizer. The recovered radioactivity represented the covalently bound [
14 C]BZ metabolites.
RESULTS
Phenol Perfusion in the Isolated Mouse Liver
HPLC analysis of both orthograde (portal vein to central vein) and retrograde (central vein to portal vein) perfusion of [ 14 C]phenol (P) in the isolated mouse liver resulted in the detection of P, phenylgucuronide (PG), phenylsulfate (PS), hydroquinone (HQ), and HQ glucuronide (HQG) in the hepatic effluent (Fig. 1) . Suspected conjugated metabolites could be nearly completely (Ͼ95%) enzymatically hydrolyzed to yield P or HQ using either crude (glucuronidase and sulfatase) or purified (glucuronidase only) glucuronidase. A small, polar peak, accounting for less than 1% of the total metabolites, which could not be hydrolyzed, was unidentifiable.
When P was perfused into the liver in the orthograde direction, greater than 80% of the radioactivity was identified as the sulfate and glucuronide conjugates of P, whereas less than 10% was composed of HQ and its glucuronide conjugate (Table 1) . Only 9% of the P remained unmetabolized. PG and PS accounted for 59% and 23% of the radioactivity, respectively. Of the HQ formed, 72% was conjugated with glucuronic acid, none with sulfate, and the remainder was recovered unconjugated.
When P was perfused into the liver in the retrograde direction, greater than 70% was recovered as free P plus its conjugates. In contrast to the results of perfusion in the orthograde direction, 26% was recovered as unchanged P, 36% as PG, and 11% as PS. A significant result of retrograde perfusion was to increase the formation of HQ and HQG to approximately 30% of the total metabolites. As in orthograde perfusion, approximately 70% of the HQ was glucuronidated and none was sulfated. Despite the reversal of flow through the liver, significant larger percentages of the collected radioactivity was identified as the unconjugated metabolites P (26%) and HQ (9%).
The time course of metabolite production during a representative orthograde perfusion is shown in Figure 2A . Metabolite levels were measured from 0 to 10 min after perfusion was initiated, after which time little radioactivity remained in the effluent. The concentrations of P, PS, and HQ released from the liver remained constant during P infusion and quickly declined when infusion was completed after 3 min. The levels of HQG and PG increased continuously during infusion and then gradually decreased after infusion was terminated. The conjugated metabolites, PG and PS, reached much higher concentrations in the perfusate samples than did P and HQ, while HQG reached an intermediate level.
The time course of metabolite release from the liver during a retrograde P experiment is shown in Figure 2B . Metabolite levels were measured from 0 to 10 min. P, PS, and HQ remained constant during the 3-min P infusion and decreased rapidly after infusion was ended. PG and HQG increased throughout infusion and slowly decreased after infusion was terminated. During retrograde perfusion, unmetabolized P reached the highest concentration in the effluent samples while PG, PS, HQ, and HQG reached intermediate levels.
Covalently Bound [ 14 C] Metabolites
Quantification of the [ 14 C] labeled metabolites covalently bound to the liver after perfusion of P, as well as after perfusion of BZ, in either the orthograde or retrograde direction, are shown in Table 2 . The amount of covalently bound material is proportional to the amount of HQ and HQG formed during each of the perfusions (Fig. 3) , but could not be correlated to the levels of any of the other metabolites found in the perfusate. The total amount of covalently bound material detected in the livers was never more than 2% of the metabolite levels found in the perfusate, and the average was less than 0.5%.
DISCUSSION
The metabolites formed during orthograde and retrograde P perfusion were qualitatively identical, but they contained some informative quantitative differences. The two notable differences between orthograde and retrograde perfusion were: (1) the overall decrease in P metabolism, represented by an increase in free P and a decrease in PG and PS detected, and (2) the increase in hydroxylation to HQ during retrograde perfusion (Table 1 ). There were also some important observations that were not altered by retrograde perfusion, namely, the absence of HQ sulfate and the ratio between HQ and HQG. If P is hydroxylated to HQ in the pericentral region of the liver, and glucuronyl transferase activity is evenly distributed across the liver sinusoid, it would be expected that more of the HQ a Mean value Ϯ standard deviation; n, 3 for all data. b Signifigantly less than retrograde P perfusion using students t-test with p ϭ 0.05.
FIG. 3. Graph showing the amount of [
14 C]labeled, covalently bound compound/mg of dry liver weight and the amount of HQ and HQG produced/mg of wet liver weight in each perfusion. The line represents a linear regression between the two values (r, 0.718).
would be glucuronidated during retrograde perfusion; however, this was not observed in our studies. The complete absence of HQ sulfate in all of our perfusion studies suggests that either HQ is a poor substrate for sulfotransferases in our system or that P is a much better substrate and therefore blocks HQ sulfation.
In order to account for these observations, we found it necessary to postulate an idealized model of the liver sinusoid that incorporates 2 major factors, metabolic zonation and microcirculation (Figs. 4A and 4B) . The model makes the following assumptions: (1) Sulfation enzymes are predominantly localized in the periportal region (Gebhardt, 1992) , while CYP 2E1 is more abundant in the pericentral region (Tsutsumi et al., 1989) . Glucuronyl transferase activity is assumed to be more or less evenly distributed across the sinusoid (Gebhardt, 1992) ; and (2) due to the non-optimal conditions employed in these experiments (e.g., the isolated state, no albumin in the perfusate, retrograde perfusion), all the sinusoids of the liver might not have been open, thus leading to the shunting of oxygenand substrate-rich perfusate away from clusters of sinusoids located in poorly perfused microregions of the liver.
During orthograde perfusion, because of metabolic zonation, much of the P is conjugated before reaching the pericentral region (Zone 3), thus preventing extensive oxidation of P (Fig.   4A ). In contrast, during retrograde perfusion, all of the P entering Zone 3 is unconjugated, leading to a vigorous phase I reaction. The high level of sulfation taking place during the orthograde perfusion, relative to the retrograde perfusion, can be explained in a similar fashion, taking into account the zonation of sulfotransferases. The absence of HQ sulfate most likely involved the poor ability of the liver to sulfate HQ in our system. This was also observed during our benzene (BZ) recirculation experiments when some unconjugated HQ was perfused in the orthograde direction and no HQ sulfate was detected in the effluent. Since glucuronyl transferase activity is evenly distributed across the sinusoid, little change was seen in total glucuronidation, including PG and HQG formation, during orthograde and retrograde perfusion.
The observation that less of the infused P was metabolized during retrograde than during orthograde perfusion can be readily accounted for in terms of the second postulate described above, namely, that retrograde perfusion leads a greater fraction of the liver sinusoids to "shut down" than orthograde perfusion, due to the unphysiological nature of the direction of microcirculation. This leads to fewer of the sinusoids being perfused with substrate, and therefore, the metabolic capacity of the liver is decreased during retrograde perfusion. Disruption of the hemodynamics within the liver during retrograde   FIG. 4 . The effect of orthograde and retrograde perfusion on phenol metabolism in the isolated, perfused mouse liver (P, phenol; PS, phenylsulfate; PG, phenylglucuronide; HQ, hydroquinone; HQG, hydroquinone glucuronide). Product Distribution: Displays the percent of total radioactivity collected identified as each compound. Metabolic Zonation: A liver sinusoid is schematically represented as a cylinder surrounded by a layer of hepatocytes and nonparenchymal cells (not shown). Sulfotransferases and cytochrome P-450 are preferentially localized in Zone 1 and Zone 3, respectively, and glucuronosyl transferase is distributed evenly across the liver lobule. perfusion and its effects on metabolism have been previously studied in the rat (Roberts et al., 1990; St-Pierre et al., 1989) , but little work has been carried out in the mouse. Our proposed model can also explain the data obtained from our liver perfusion studies using BZ as a substrate (Hedli, et al., 1997) . As with retrograde P perfusion, retrograde BZ perfusion led to an overall decrease in metabolism, and analysis of BZ perfusion studies indicated that BZ hydroxylation occured closer to the central vein than metabolite sulfation.
Additional evidence for hepatic zonation can be found by examining the graphs displaying metabolite release versus time for both orthograde and retrograde P perfusion (Fig. 2) . Ballinger et al. (1995) used the difference in transit time of P metabolites through the rat liver in the orthograde and retrograde directions to measure liver zonation. The concept is that, the farther through the sinusoid a substrate has to travel before being metabolized, the longer the transit time will be. This happens because the substrate will distribute throughout the sinusoid and the surrounding hepatocytes until it is metabolized. Thus, in the orthograde direction, the farther away from the portal vein that metabolism takes place the longer the transit time will be. The metabolite(s) that are released from the liver first should have traveled the shortest distance in the sinusoid before being metabolized. Figure 2 shows that, during orthograde P perfusion, PS is the first metabolite released, while during retrograde perfusion, HQ is the first metabolite released. This supports the theory that sulfation of P occurs closer to the portal vein while hydroxylation of P occurs closer to the central vein.
The dose of P used in these perfusion studies, as well as the dose used in the BZ perfusion studies (Hedli et al., 1997) , were biologically relevant levels. Snyder et al. (1981) found the concentration of BZ in the blood of mice exposed to 100 ppm and 300 ppm BZ for 6 h to be approximately 10 M and 100 M, respectively. The estimated average concentration of BZ reaching the liver during orthograde perfusion was 87 M, which is well within the range of the blood concentrations measured at the 2 hematotoxic doses mentioned above. (This value is an estimate based on measurements taken before perfusion and is in error to the extent that some small amount of BZ may have been lost because of its volatility.) The average level of P used during orthograde perfusion was 14.4 M. This value, although significantly less than that used during BZ perfusion, is 10-fold higher than that found in the blood of mice after exposure to BZ for 6 h at 50 ppm (Sabourin et al., 1988) . It is also higher than the concentration of P leaving the liver during our BZ perfusions. Unfortunately, little or no data is available on the blood concentrations of P detected after a given dose of P in the mouse. Based on data obtained in the rat by Cassidy and Houston (1984) , we have estimated that the levels used are levels that may approximate those resulting from an exposure to P at a dose in the range of 10 mg/kg.
The current study allows us to compare the hepatic metabolites of P and BZ in the intact mouse liver. This is significant because the hematotoxicity seen in animals after BZ, but not P, administration is believed to be caused by a qualitative or quantitative difference in hepatic metabolism. Among the possible explanations of this phenomenon are: (1) Hepatic BZ metabolism leads to the production of hematotoxic compounds, such as trans,trans-muconaldehyde and its derivatives, which cannot be derived from P (Goldstein et al., 1982) ; (2) P can be conjugated, and therefore detoxified, by extrahepatic tissues to a greater extent than BZ (Cassidy and Houston, 1984) . Thus, the actual amount of P reaching the liver to be converted to hematotoxic intermediates is greatly reduced; (3) the heterogeneous distribution of metabolizing enzymes within the liver acinus causes an increase in the amount of unconjugated, hematotoxic, hydroxylated metabolites released from the liver during BZ metabolism than during P metabolism (Schlosser et al., 1995) . Our studies have focused on the zonation issue. It is important to recognize that the 3 hypotheses are not mutually exclusive and that it may be a combination of the 3 which leads to BZ-induced hematotoxicity.
The importance of metabolic zonation in explaining the differences in metabolism of BZ and P has been presented previously by Schlosser et al. (1995) . These authors predicted that more unconjugated P and HQ should be released from the liver after BZ metabolism than after P metabolism. Indeed, comparison of orthograde BZ and orthograde P perfusion shows that a greater percentage of the collected radioactivity is released as the unconjugated, hematotoxic metabolite HQ after BZ than after P orthograde perfusion. These higher levels of HQ released after BZ metabolism, in combination with the free P released, are of interest because of the possible implications this may have in BZ-induced hematotoxicity. Administration of HQ alone produces little hematotoxicity; however, co-administration of HQ with P can mimic the effects of BZ exposure in vivo, as measured by a loss in bone marrow cellularity (Eastmond et al., 1987) , or a decrease in 59 Fe utilization by erythrocytes (Guy et al., 1990) . In addition, an increase in covalent binding to macromolecules in the bone marrow is seen after administration of P and HQ together rather than after either metabolite alone (Subrahmanyam, et al., 1990) .
The involvement of HQ in the development of BZ-induced leukemia in humans has been strongly supported by the findings of Rothman et al. (1997) . In the bone marrow, HQ can be metabolized, via myeloperoxidase, to 1,4-benzoquinone (BQ), the proposed toxic intermediate of HQ (Eastmond et al., 1987; Smith et al., 1989) . BQ can then be reduced back to HQ, via NADPH:quinone oxidoreductase (NQO1) (Ross, 1996) . Recent studies have revealed that a mutation in NQO1, which decreases its activity, leads to an increase in the susceptibility of humans to BZ-induced hematotoxicity (Rothman et al., 1997) . This demonstrates that the balance between BQ and HQ within the bone marrow may be essential in determining toxicity. The presence of P in the bone marrow may be important in pushing the equilibrium toward BQ (Smith et al., 1989) . The increase in the release of HQ after the hepatic metabolism of BZ as compared to P, supports the idea that an interaction between HQ and P may play an important role in the bone marrow toxicity seen after BZ exposure.
The potential reactivity and toxicity of HQ in vivo is also supported by the data collected from the radioactivity found covalently bound in the liver after perfusion of either P or BZ. The amount of radioactivity is positively correlated with the amount of total HQ produced in each of the perfusions (Fig. 3) . The correlation was similar when the results were separated into only the P or only the BZ perfusions (data not shown). Although neither P nor BZ is hepatotoxic, this demonstrates that the majority of the covalent binding seen in the liver after either P or BZ perfusion can be attributed to the ability of HQ, or a derivative of HQ, such as BQ, to covalently bind to macromolecules in our system. Similar results have been reported both in vivo (Snyder et al., 1978) and in vitro, after incubation of BZ in microsomes (Tunek et al., 1978) .
These studies were done in order to further elucidate the role of hepatic zonation in causing differences in the metabolism of BZ and P when administered individually. Gilmour et al. (1986) demonstrated that when P and BZ are present together, the metabolism of each can be altered by their competition for CYP 2E1. This situation may arise after BZ exposure, when unmetabolized BZ and small amounts of free P are present in the blood. As indicated above, we do not contend that these perfusion studies replicate exactly what occurs in vivo. They are, however, helpful in confirming the heterogenous distribution of metabolizing enzymes within the liver acinus and in examining the differences in metabolism of BZ and P in the intact liver, which may prove helpful in identifying the metabolite(s) responsible for BZ-induced hematotoxicity.
